The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19
NCT ID: NCT04591704
Last Updated: 2021-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2020-03-20
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of COVID-19 on Diabetes Mellitus
NCT04592055
The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19
NCT04663659
Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19
NCT04695158
Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes
NCT04550403
Glycaemia and Cardiac Function in Patients With COVID-19
NCT04410718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19.
The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic groups
COVID-19 patients with diabetes mellitus
hospitalisation, necessity of ICU, mortality rate, lung involvement
hospitalisation, necessity of ICU, mortality rate, lung involvement
Control groups
COVID-19 patients without diabetes mellitus
hospitalisation, necessity of ICU, mortality rate, lung involvement
hospitalisation, necessity of ICU, mortality rate, lung involvement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hospitalisation, necessity of ICU, mortality rate, lung involvement
hospitalisation, necessity of ICU, mortality rate, lung involvement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant patients
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uşak University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cevdet Duran
Role: PRINCIPAL_INVESTIGATOR
Uşak Üniversitesi Tıp fak
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Usak University Training and Research Hospital
Uşak, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UU-DM003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.